A Global Prospective observationAl Study of Real-world management of patients With atrial fibrillation at High Risk of Stroke (GARDENIA)
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: ANTHOS THERAPEUTICS
- Execution start: 20/12/2022
- End of execution: 31/10/2024
- IP: ROSA MACIAS RUIZ
